CIK 0001374690 · Non-accelerated filer<br>Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203857670
- Phone
- 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- Open-market buys, last 90 days
- $382,086
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$382,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-22 | Shankar Gopi Chief Development Officer | Grant or award | +23,306 | 50,806 | ||
| 2025-01-22 | Shankar Gopi Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +139,838 | 139,838 | ||
| 2025-01-22 | Clayton Russell Chief Medical Officer | Grant or award | +23,306 | 45,806 | ||
| 2025-01-22 | Clayton Russell Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +139,838 | 139,838 | ||
| 2025-01-22 | BEN-MAIMON CAROLE President and CEO | Grant or award | +91,000 | 387,208 | ||
| 2025-01-22 | BEN-MAIMON CAROLE President and CEO | Grant or award · Stock Option (Right to Buy) | +546,000 | 546,000 | ||
| 2025-01-22 | Celano Michael Chief Financial Officer | Grant or award | +34,185 | 178,181 | ||
| 2025-01-22 | Celano Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +205,111 | 205,111 | ||
| 2024-05-29 | Flynn James E Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2024-05-29 | THOMAS FRANK E Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2024-05-29 | LEFF JONATHAN S Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2024-05-29 | SHERMAN JEFFREY W Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2024-05-29 | Truitt Joseph Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2024-05-29 | Hamilton Thomas Edward Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2024-02-16 | Hamilton Thomas Edward Director | Purchase | +57,208 | $8.74 | $500K | 564,798 |
| 2024-02-16 | Flynn James E Director | Purchase | +1,430,206 | $8.74 | $12.5M | 6,151,389 |
| 2024-02-16 | Flynn James E Director | Purchase | +1,430,206 | $8.74 | $12.5M | 6,151,406 |
| 2024-02-16 | Flynn James E Director | Purchase | +1,430,205 | $8.74 | $12.5M | 4,207,982 |
| 2024-02-14 | THOMAS FRANK E Director | Purchase | +2,000 | $11.00 | $22K | 2,000 |
| 2024-01-17 | Shankar Gopi Chief Development Officer | Grant or award | +22,500 | 27,500 |
Page 3 of 7 · 136 trades